Relmada Therapeutics, Inc.

RLMD US75955J4022

🆔
Registration No.
E0297422012-5
💰
Capitalization
Small-cap

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

🔗
Website
https://www.relmada.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
38
🙍
Insiders
5
Person Price Shares Total Published Completed
Traversa Sergio
CEO 		0.74
USD 		55,976
Bought 		41,422
USD 		26/08/2025 28/08/2025
Traversa Sergio
CEO 		0.67
USD 		129,455
Bought 		86,735
USD 		26/08/2025 27/08/2025
Traversa Sergio
CEO 		0.62
USD 		80,545
Bought 		49,938
USD 		26/08/2025 26/08/2025
Shenouda Maged
CFO 		0.52
USD 		60,000
Bought 		31,422
USD 		16/05/2025 20/05/2025
Traversa Sergio
CEO 		0.56
USD 		147,686
Bought 		82,246
USD 		16/05/2025 20/05/2025
Shenouda Maged
CFO 		0.52
USD 		60,000
Bought 		31,422
USD 		16/05/2025 20/05/2025
Traversa Sergio
CEO 		0.56
USD 		147,686
Bought 		82,246
USD 		16/05/2025 20/05/2025
Traversa Sergio
CEO 		0.50
USD 		30,000
Bought 		14,994
USD 		16/05/2025 19/05/2025
Traversa Sergio
CEO 		0.50
USD 		30,000
Bought 		14,994
USD 		16/05/2025 19/05/2025
Shenouda Maged
CFO 		0.49
USD 		90,000
Bought 		43,686
USD 		16/05/2025 19/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Relmada Therapeutics, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Traversa Sergio 16 1,469,321.87 91,832.62 29/01/2024 28/08/2025
Shenouda Maged 13 491,933.52 37,841.04 29/01/2024 20/05/2025
Ence Chuck 5 357,580.33 71,516.07 29/01/2024 16/05/2025
Kelly Paul Edward 3 236,870.00 78,956.67 09/09/2024 16/05/2025
Casamento Charles J 1 33,280.00 33,280.00 09/09/2024 09/09/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.